HIV and chemoprophylaxis, the importance of considering social structures alongside biomedical and behavioral intervention

Social Science and Medicine

Volumn 75, Issue 9, 2012, Pages 1555-1561

  Roberts, Eric T ^a   Matthews, Derrick D ^b  

^a Mailman School of Public Health ^*  (United States)

^b IL   (United States)

Author keywords

HIV; Microbicide; Prophylaxis; Randomized control trial; Structural

Indexed keywords

EMTRICITABINE; TENOFOVIR;

DISEASE; HUMAN IMMUNODEFICIENCY VIRUS; PUBLIC HEALTH; SOCIAL STRUCTURE;

ARTICLE; BEHAVIOR CHANGE; CHEMOPROPHYLAXIS; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONDOM; DRUG EFFICACY; FUNDING; HEALTH BEHAVIOR; HEALTH CARE PLANNING; HEALTH PROGRAM; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; PATIENT ATTITUDE; PUBLIC HEALTH SERVICE; RISK FACTOR; RISK REDUCTION; SOCIAL CARE; SOCIAL ENVIRONMENT; SOCIAL STRUCTURE; VIRUS TRANSMISSION;

ANTIVIRAL AGENTS; CHEMOPREVENTION; FEMALE; HEALTH BEHAVIOR; HEALTH PROMOTION; HIV INFECTIONS; HUMANS; INTERPERSONAL RELATIONS; MALE; MODELS, BIOLOGICAL; PROGRAM EVALUATION; PSYCHOLOGICAL THEORY; PUBLIC HEALTH PRACTICE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84865653865     PISSN: 02779536     EISSN: 18735347     Source Type: Journal    
DOI: 10.1016/j.socscimed.2012.02.016     Document Type: Article

References (87)

1. Abdool Karim Q., Abdool Karim S.S., Frohlich J.A., Grobler A.C., Baxter C., Mansoor L.E., et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010, 329(5996):1168-1174.
2. Bertozzi S.M., Laga M., Bautista-Arredondo S., Coutinho A. Making HIV prevention programmes work. The Lancet 2008, 372(9641):831-844.
3. Binford L. An alternative anthropology: exercising the preferential option for the poor. Violence in war and peace: An anthology 2004, Blackwell Publishing Ltd, Oxford, UK. N. Scheper-Hughes, P. Bourgois (Eds.).
4. Blankenship K.M., Bray S.J., Merson M.H. Structural interventions in public health. AIDS 2000, 14:S11-S21.
5. Blankenship K.M., Friedman S., Dworkin S., Mantell J. Structural interventions: concepts, challenges and opportunities for research. Journal of Urban Health 2006, 83(1):59-72.
6. Bourgois P. The moral economies of homeless heroin addicts: confronting ethnography, HIV risk, and everyday violence in San Francisco shooting encampments. Substance Use & Misuse 1998, 33(11):2323-2351.
7. Bourgois P. Anthropology and epidemiology on drugs: the challenges of cross-methodological and theoretical dialogue. The International Journal of Drug Policy 2002, 13(4):259-269.
8. Bourgois P., Schonberg J. Righteous dopefiend 2008, University of California Press, Berkeley.
9. Buchbinder S., Liu A. Pre-exposure prophylaxis and the promise of combination prevention approaches. AIDS and Behavior 2011, 15(0):72-79.
10. Burris S., Cameron E. The case against criminalization of HIV transmission. JAMA: The Journal of the American Medical Association 2008, 300(5):578-581.
11. Clarke A.E., Shim J.K., Mamo L., Fosket J.R., Fishman J.R. Biomedicalization: technoscientific transformations of health, illness, and U.S. biomedicine. American Sociological Review 2003, 68(2):161-194.
12. Coates T.J., Richter L., Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. The Lancet 2008, 372(9639):669-684.
13. Cockerham W.C. Health lifestyle theory and the convergence of agency and structure. Journal of Health and Social Behavior 2005, 46(1):51-67.
14. Cohen J. A powerful and perplexing new HIV prevention tool. Science 2010, 330(6009):1298-1299.
15. Cohen J. HIV treatment as prevention. Science 2011, 334(6063):1628.
16. Cohen M.S., Chen Y.Q., McCauley M., Gamble T., Hosseinipour M.C., Kumarasamy N., et al. Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine 2011, 365(6):493-505.
17. CONRAD FDA and CONRAD chart U.S. regulatory path for 1% tenofovir gel for HIV prevention: Collaborative meeting with key stakeholders 2010, Arlington, VA.
18. Department of Health National HIV and syphilis antenatal sero-prevalence survey in South Africa 2004 2005, Pretoria, Gauteng, South Africa.
19. Des Jarlais D.C. Structural interventions to reduce HIV transmission among injecting drug users. AIDS 2000, 14:S41-S46.
20. Diaz R.M., Ayala G., Bein E. Sexual risk as an outcome of social oppression: data from a probability sample of Latino gay men in three U.S. cities. Cultural Diversity & Ethnic Minority Psychology 2004, 10(3):255-267.
21. Diez-Roux A.V. Bringing context back into epidemiology: variables and fallacies in multilevel analysis. American Journal of Public Health 1998, 88(2):216-222.
22. Donnell D., Baeten J.M., Kiarie J., Thomas K.K., Stevens W., Cohen C.R., et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. The Lancet 2010, 375(9731):2092-2098.
23. Dugger C.W. African studies give women hope in HIV fight 2010, The New York Times, New York, NY.
24. Dunn C., Deroo L., Rivara F.P. The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction 2001, 96(12):1725-1742.
25. Eaton L., Kalichman S. Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Current HIV/AIDS Reports 2007, 4(4):165-172.
26. Farmer P. AIDS and accusation: Haiti and the geography of blame 1992, University of California Press, Berkeley.
27. Fleming D.T., Wasserheit J.N. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sexually Transmitted Infections 1999, 75(1):3.
28. Gangamma R., Slesnick N., Toviessi P., Serovich J. Comparison of HIV risks among gay, lesbian, bisexual and heterosexual homeless youth. Journal of Youth and Adolescence 2008, 37(4):456-464.
29. Golin C.E., Earp J., Tien H.C., Stewart P., Porter C., Howie L. A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. Journal of Acquired Immune Deficiency Syndromes 2006, 42(1):42-51.
30. Grant R.M., Lama J.R., Anderson P.L., McMahan V., Liu A.Y., Vargas L., et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine 2010, 363(27):2587-2599.
31. Grov C., Parsons J.T. Bug chasing and gift giving: the potential for HIV transmission among barebackers on the internet. AIDS Education and Prevention 2006, 18(6):490-503.
32. Gupta G.R., Parkhurst J.O., Ogden J.A., Aggleton P., Mahal A. Structural approaches to HIV prevention. The Lancet 2008, 372(9640):764-775.
33. Gutierrez G. A theology of liberation: History, politics, and salvation 1973, Orbis, Maryknoll, NY.
34. Hatzenbuehler M.L., McLaughlin K.A., Keyes K.M., Hasin D.S. The impact of institutional discrimination on psychiatric disorders in lesbian, gay, and bisexual populations: a prospective study. American Journal of Public Health 2010, 100(3):452-459.
35. Institute of Medicine Methodological challenges in biomedical HIV prevention trials 2008, The National Academies Press, Washington, D.C.
36. HIV & AIDS in Africa: Beyond epidemiology 2004, Blackwell Publishing, Oxford, UK. E. Kalipeni, S. Craddock, J.R. Oppong, J. Ghosh (Eds.).
37. Kaplan G.A. The role of epidemiologists in eradicability of poverty. The Lancet 1998, 352(9140):1627-1628.
38. Kaplan G.A. What's wrong with social epidemiology, and how can we make it better?. Epidemiologic Reviews 2004, 26:124-135.
39. Katz M.H. Interventions to increase interventions are needed. Journal of Public Health Management and Practice 2008, 14(3):224-227.
40. Krieger N. Epidemiology and the web of causation: has anyone seen the spider?. Social Science & Medicine 1994, 39(7):887-903.
41. Levins R. Why programs fail. Monthly Review 2010, 61(10).
42. Malta M., Strathdee S.A., Magnanini M.M.F., Bastos F.I. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction 2008, 103(8):1242-1257.
43. McGinnis J.M., Williams-Russo P., Knickman J.R. The case for more active policy attention to health promotion. Health Affairs 2002, 21(2):78-93.
44. McGowan I. Microbicides for HIV prevention: reality or hope?. Current Opinion in Infectious Diseases 2010, 23(1):26-31.
45. McLaren L., McIntyre L., Kirkpatrick S. Rose's population strategy of prevention need not increase social inequalities in health. International Journal of Epidemiology 2010, 39(2):372-377.
46. McMichael A.J. Prisoners of the proximate: loosening the constraints on epidemiology in an age of change. American Journal of Epidemiology 1999, 149(10):887-897.
47. McNeil D.G. Daily pill greatly lowers AIDS risk, study finds 2010, The New York Times, New York, NY.
48. Merson M.H., O'Malley J., Serwadda D., Apisuk C. The history and challenge of HIV prevention. The Lancet 2008, 372(9637):475-488.
49. Meyer I.H. Minority stress and mental health in gay men. Journal of Health and Social Behavior 1995, 36(1):38-56.
50. Michael N.L. Oral preexposure prophylaxis for HIV - another arrow in the quiver?. New England Journal of Medicine 2010, 363(27):2663-2665.
51. Morojele N.K., Brook J.S., Kachieng'a M.A. Perceptions of sexual risk behaviours and substance abuse among adolescents in South Africa: a qualitative investigation. AIDS Care 2006, 18(3):215-219.
52. Munthe C. The goals of public health: an integrated, multidimensional model. Public Health Ethics 2008, 1(1):39-52.
53. Myers G.M., Mayer K.H. Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings. AIDS Patient Care and STDs 2011, 25(2):63-71.
54. Navarro V. Social capital. Response. International Journal of Epidemiology 2005, 34(2):480-481.
55. Ng B.E., Butler L.M., Horvath T., Rutherford G.W. Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection. Cochrane Database of Systematic Reviews 2011, (3):CD001220.
56. Ory M.G., Lee Smith M., Mier N., Wernicke M.M. The science of sustaining health behavior change: the health maintenance consortium. American Journal of Health Behavior 2010, 34(6):647-659.
57. Padian N.S., Buvé A., Balkus J., Serwadda D., Cates W. Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward. The Lancet 2008, 372(9638):585-599.
58. Park A. Top 10 medical breakthroughs: AIDS drugs lower the risk of HIV infection 2010, TIME.
59. Parker R.G., Easton D., Klein C.H. Structural barriers and facilitators in HIV prevention: a review of international research. AIDS 2000, 14:S22-S32.
60. Parry C., Petersen P., Carney T., Dewing S., Needle R. Rapid assessment of drug use and sexual HIV risk patterns among vulnerable drug-using populations in Cape Town, Durban and Pretoria, South Africa. Journal of Social Aspects of HIV/AIDS Research Alliance 2008, 5(3):113-119.
61. Parsons J.T., Rosof E., Punzalan J.C., Di Maria L. Integration of motivational interviewing and cognitive behavioral therapy to improve HIV medication adherence and reduce substance use among HIV-positive men and women: results of a pilot project. AIDS Patient Care and STDs 2005, 19(1):31-39.
62. Pearce N. Traditional epidemiology, modern epidemiology, and public health. American Journal of Public Health 1996, 86(5):678-683.
63. Piot P., Bartos M., Larson H., Zewdie D., Mane P. Coming to terms with complexity: a call to action for HIV prevention. The Lancet 2008, 372(9641):845-859.
64. Poundstone K.E., Strathdee S.A., Celentano D.D. The social epidemiology of human immunodeficiency virus/acquired immunodeficiency syndrome. Epidemiologic Reviews 2004, 26(1):22-35.
65. Prejean J., Song R., Hernandez A., Ziebell R., Green T., Walker F., et al. Estimated HIV incidence in the United States, 2006-2009. PLoS ONE 2011, 6(8):e17502.
66. Pronyk P.M., Hargreaves J.R., Kim J.C., Morison L.A., Phetla G., Watts C., et al. Effect of a structural intervention for the prevention of intimate-partner violence and HIV in rural South Africa: a cluster randomised trial. The Lancet 2006, 368(9551):1973-1983.
67. Quinn T.C., Wawer M.J., Sewankambo N., Serwadda D., Li C., Wabwire-Mangen F., et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. New England Journal of Medicine 2000, 342(13):921-929.
68. Rausch D., Dieffenbach C., Cheever L., Fenton K. Towards a more coordinated federal response to improving HIV prevention and sexual health among men who have sex with men. AIDS and Behavior 2011, 15(0):107-111.
69. Rose G. Sick individuals and sick populations. International Journal of Epidemiology 1985, 14(1):32-38.
70. Rotheram-Borus M.J., Swendeman D., Chovnick G. The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention. Annual Review of Clinical Psychology 2009, 5(1):143-167.
71. Rothman K.J., Adami H.-O., Trichopoulos D. Should the mission of epidemiology include the eradication of poverty?. The Lancet 1998, 352(9130):810-813.
72. Ryan C., Huebner D., Diaz R.M., Sanchez J. Family rejection as a predictor of negative health outcomes in white and Latino lesbian, gay, and bisexual young adults. Pediatrics 2009, 123(1):346-352.
73. Sawyer K.M., Wechsberg W.M., Myers B.J. Cultural similarities and differences between a sample of Black/African and colored women in South Africa: convergence of risk related to substance use, sexual behavior, and violence. Women & Health 2006, 43(2):73-92.
74. Shilts R. And the band played on: Politics, people, and the AIDS epidemic 1987, St. Martin's Press, New York.
75. Shoptaw S., Rotheram-Fuller E., Landovitz R.J., Wang J., Moe A., Kanouse D.E., et al. Non-occupational post exposure prophylaxis as a biobehavioral HIV-prevention intervention. AIDS Care 2008, 20(3):376-381.
76. Steckler A., McLeroy K.R. The importance of external validity. American Journal of Public Health 2008, 98(1):9-10.
77. Stein Z.A. HIV prevention: the need for methods women can use. American Journal of Public Health 1990, 80(4):460-462.
78. Stein H. Beyond the world bank agenda: An institutional approach to development 2008, The University of Chicago Press, Chicago, IL.
79. Sumartojo E. Structural factors in HIV prevention: concepts, examples, and implications for research. AIDS 2000, 14:S3-S10.
80. Susser M., Susser E. Choosing a future for epidemiology: I. Eras and paradigms. American Journal of Public Health 1996, 86(5):668-673.
81. Susser M., Susser E. Choosing a future for epidemiology: II. From black box to Chinese boxes and eco-epidemiology. American Journal of Public Health 1996, 86(5):674-677.
82. Toobert D., Strycker L., Glasgow R., Barrera M., Angell K. Effects of the Mediterranean lifestyle program on multiple risk behaviors and psychosocial outcomes among women at risk for heart disease. Annals of Behavioral Medicine 2005, 29(2):128-137.
83. Trussell J. Contraceptive efficacy. Contraceptive technology: Nineteenth revised edition 2007, Ardent Media, New York, NY. R. Hatcher, J. Trussell, A. Nelson, W. Cates, F. Stewart, D. Kowal (Eds.).
84. UNAIDS. (2009). AIDS epidemic update: November 2009. In World Health Organization (Ed.).
85. UNAIDS Chapter 4-HIV treatment. Global report: UNAIDS report on the global AIDS epidemic 2010.
86. Waitzkin H. Political economic systems and the health of populations: historical thought and current directions. Macrosocial determinants of population health 2007, Springer, New York. S. Galea (Ed.).
87. Zenilman J.M. Sexually transmitted diseases. Infectious disease epidemiology: Theory and practice 2007, Jones and Bartlett Publishers, Sudbury, MA. K.E. Nelson, C.F. Masters Williams (Eds.).